Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Olga Pedrini"'
Autor:
Chiara Capelli, Olga Pedrini, Gisella Cassina, Orietta Spinelli, Silvia Salmoiraghi, Josée Golay, Alessandro Rambaldi, Ursula Giussani, Martino Introna
Publikováno v:
Haematologica, Vol 99, Iss 6 (2014)
Externí odkaz:
https://doaj.org/article/c4c3504adbb64a8a96392d5eda09fa36
Autor:
Mara Magri, Chiara Capelli, Marco Passera, Elisa Gotti, Josée Golay, Francesca Vailati, Gianmaria Borleri, Martino Introna, Alessandro Rambaldi, Claudio Farina, Olga Pedrini
Publikováno v:
Cytotherapy. 20:262-270
Background We analyzed the results of routine sterility testing performed in our center over the last 10 years, in the context both hematopoietic stem cell transplantation (HSCT) and Advanced Therapeutic Medicinal Products (ATMPs). Methods For steril
Autor:
Katia Todoerti, Valentina Barbui, Olga Pedrini, Marta Lionetti, Gianluca Fossati, Paolo Mascagni, Alessandro Rambaldi, Antonino Neri, Martino Introna, Luigia Lombardi, Josée Golay
Publikováno v:
Haematologica, Vol 95, Iss 2 (2010)
Background The histone deacetylase inhibitor ITF2357 has potent cytotoxic activity in multiple myeloma in vitro and has entered clinical trials for this disease.Design and Methods In order to gain an overall view of the activity of ITF2357 and identi
Externí odkaz:
https://doaj.org/article/a1f3057522f148d6afed1d17f7626150
Autor:
Francesca Masciocchi, Attilio Rovelli, Giovanna D'Amico, Sergio Cortelazzo, Adriana Balduzzi, Anna Grassi, Ettore Biagi, Martino Introna, Olga Pedrini, Giovanna Lucchini, Paolo Perseghin, Andrea Biondi, Giuseppe Gaipa, Daniela Longoni, Chiara Capelli, Stefania Galimberti, Erica Dander, Enrico Maria Pogliani, Fabio Pavan, Irene Cavattoni, Matteo Parma, Sara Deola, Josée Golay, Alessandra Algarotti, Daniela Belotti, Caterina Micò, Alessandro Rambaldi
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:375-381
This phase I multicenter study was aimed at assessing the feasibility and safety of intravenous administration of third party bone marrow–derived mesenchymal stromal cells (MSC) expanded in platelet lysate in 40 patients (15 children and 25 adults)
Autor:
Valentina Barbui, Olga Pedrini, Luigia Lombardi, Paolo Mascagni, Martino Introna, Katia Todoerti, Alessandro Rambaldi, Marta Lionetti, Gianluca Fossati, Josée Golay, Antonino Neri
Publikováno v:
Haematologica. 95:260-269
Background The histone deacetylase inhibitor ITF2357 has potent cytotoxic activity in multiple myeloma in vitro and has entered clinical trials for this disease.Design and Methods In order to gain an overall view of the activity of ITF2357 and identi
Autor:
Josée Golay, Olga Pedrini, Alessandro Rambaldi, Martino Introna, Chiara Capelli, Silvia Salmoiraghi, Gisella Cassina, Ursula Giussani, Orietta Spinelli
Publikováno v:
Haematologica. 99(6)
Human bone marrow mesenchymal stromal cells (BM-MSC) represent one of the most investigated “advanced therapeutic medicinal products”.[1][1] Recent safety concerns have focused attention on the possible malignant transformation due to mutations a
Autor:
Francesco Colotta, Veronica Patton, Roberta Ceruti, Marina Ciomei, Josée Golay, Martino Introna, Alessandro Rambaldi, Rachele Alzani, Enrico Pesenti, Olga Pedrini, Alessia Casolaro, Clara Albanese
Publikováno v:
Experimental hematology. 38(4)
The aim of the work was to determine and characterize, in vitro and in vivo, the therapeutic activity of PHA-793887, a new potent pan-cdk inhibitor, in the context of hematopoietic neoplasms.Thirteen leukemic cell lines bearing different cytogenetic
Autor:
Piero Bellavita, Agnese Salvadè, Benedetta Cabiati, Olga Pedrini, Valentina Barbui, Paolo Perseghin, Josée Golay, Ettore Biagi, Andrea Biondi, Daniela Belotti, Chiara Capelli, Elisa Gotti, Gianmaria Borleri, Martino Introna, Alessandro Rambaldi
BACKGROUND AIMS: Human multipotent mesenchymal stromal cells (hMSC) are considered good candidates for a growing spectrum of cell therapies. We have validated a protocol that makes use of the washouts of discarded collection sets, left over at the en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca01925e857f7110f67295836fb7d2d
http://hdl.handle.net/10281/14925
http://hdl.handle.net/10281/14925
Autor:
Martino Introna, Olga Pedrini, Flavio Leoni, Guido Finazzi, Josée Golay, Alessandro Rambaldi, Paolo Mascagni, Ariel Amaru Calzada
Publikováno v:
Experimental Hematology. 41:253-260.e2
We investigated whether clinically achievable concentrations of the histone deacetylase (HDAC) inhibitors givinostat and hydroxyurea induce synergistic cytotoxicity in Jak2(V617F) cells in vitro and through which possible mechanism. Givinostat and hy
Autor:
Martino Introna, Guido Finazzi, Josée Golay, Ariel Amaru, Gianluca Fossati, Giacomo Tuana, Katia Todoerti, Luca Donadoni, Anna Pellicioli, Antonino Neri, Olga Pedrini, Alessandro Rambaldi, Luigia Lombardi
Publikováno v:
Blood. 116:797-797
Abstract 797 We have previously shown that the pan-HDAC inhibitor ITF2357 has strong cytotoxic activity against cells from patients with myeloproliferative neoplasms (MPN) bearing JAK2 mutation at position 617. Indeed ITF2357 inhibited colony growth